Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children
Most Cited Paper
in Pediatric health and respiratory diseases
18 Months Post-Publication
Class of 2026
“Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026/
Topics
mRNA-1653 · Human metapneumovirus · parainfluenza virus type 3 (PIV3) · mRNA-based combination vaccine · membrane-anchored fusion protein antigen design · seropositive pediatric population · phase 1b dose-ranging study · neutralizing antibody titers · preF binding antibody · postF binding antibody · preF-biased antibody response · geometric mean fold-rise · Local adverse reactions · Systemic adverse reactions · prime-boost immunization schedule · vaccine reactogenicity · pediatric respiratory illness prevention · dose-level comparison (10-μg vs 30-μg) · observer-blind placebo-controlled design · immunogenicity in seropositive individuals
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459